ClinicalTrials.gov
public full text
Public Domain
Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)
This is a multicenter, open-label, single-dose pharmacokinetic (PK) study. Infants, children, and adolescents will receive a single 10 mg/kg dose of telavancin infused intravenously (IV) over 60 minutes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Editorial: Integrated PK/PD and drug metabolism approaches in drug development and evaluation.#636365
- Telmisartan+Amlodipine Fixed Dose Combination in Hypertension#387243
- Safety and PK/PD of RTA 1701 in Healthy Adults#857808
- Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension#840619
- Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension#833113
Record · ID 1085890
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive